Статья
Синдром обструктивного апноэ сна -фактор риска артериальной гипертонии
Синдром обструктивного апноэ сна (COAC) является фактором риска развития сердечно-сосудистых заболеваний Результаты эпидемиологических, обсервационных и экспериментальных работ подтверждают существенную роль COAC в формировании артериальной гипертонии (AT) посредством хронической симпатической активации и нейрогуморальных изменений, инициируемых во время сна Особенно большое значение проблема COAC приобретает в развитии рефрактерной AT Лечение COAC методом СИПАП-терапии приводит не только к устранению обструктивных нарушений дыхания во время сна, но и зачастую снижает артериальное давление у больных AT и улучшает прогноз течения сердечнососудистых заболеваний
1. Young Т, Palta М, Dempsey J et al. The occurrence of sleep-disordered breathing among middle-aged adults N Engl J Med 1993,328 1230-5
2. Профилактика, диагностика и лечение первичной артериальной гипертонии в Российской Федерации Первый доклад экспертов Научного общества по изучению артериальной гипертонии, Всероссийского научного обіцества кардиологов и Межведомственного совета по сердечнососудистым заболеваниям (ДАТ 1 ) РМЖ, 2000, 8 (8)
3. Coccagna G, Mantovam М, Bngnam F, Parchi С, Lugaresi E Tracheostomy т hypersomnia with periodic breathing Bull Physiopathol Respir (Nancy) 1972 Sep-Oct, 8 (5) 1217-27
4. Guilleminault C, Dement WC, Monod NNouv Presse Med 1973May 19, 2 (20) 1355-8
5. Lugaresi E, Coccagna G, Cmgnotta F et al. Breathing during sleep m man in normal and pathological conditions Adv Exp Med Biol 1978,99 35-45
6. Kales A, Bvcler EO, CadieuxRJ et al. Sleep apnoea in a hypertensive population Lancet 1984 Nov 3, 2 (8410) 1005-8
7. Fletcher EC, DeBehnke RD, Lovoi MS, Gonn AB Undiagnosed sleep apnea in patients with essential hypertension Ann Intern Med 1985Aug 103 (2) 190-5
8. Williams AJ, Houston D, Fvnberg S et al. Sleep apnea syndrome and essential hypertension Am J Cardiol 1985 Apr 1,55 (8) 1019-22
9. Lugaresi E Cingnotta F, Coccagna G, Piana C Some epidemiological data on snonng and cardiocirculatory disturbances Sleep 1980, 3 (3-4) 221-4
10. Lawe P, Herer P, Peled R et al. Sleep 1995 Apr, 18 (3) 149-5 7
11. Waller PC, Bhopal RS Is snonng a cause of vascular disease? An epidemiological review Lancet 1989, I 143-6
12. Newman AB, Nieto FJ, Guidry U et al. Relation of Sleep-disordered Breathing to Cardiovascular Disease Risk Factors The Sleep Heart Health Study Am J Epidemiol 2001, 154 50-9
13. Hla KM, Young TB, Bidwell T et al. Sleep apnea and hypertension a population-based study Ann Intern Med 1994, 120 382-8
14. Hedner J, Ejnell H, Sellgren J et al. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension J Hypertens Suppl 1988 Dec, 6 (4) S529-31
15. Baylor P, Mouton A, Shamoon HH, Goebel P Increased norepinephnne vanability in patients with sleep apnea syndrome Am J Med 1995 Dec, 99 (6) 611-5
16. Carlson JT, Hedner JA, Sellgren J et al. Depressed baroreflex sensitivity m patients with obstructive sleep apnea Am J Respir Cnt Care Med 1996 Nov, 154 (5) 1490-6
17. Carley DW, Trbovic S, Radulovacki M Sleep apnea in normal and REM sleep-depnved normotenswe Wistar-Kyoto and spontaneously hypertensive (SHR) rats Physiol Behav 1996,59 827-31
18. Hofer MA Role of carotid sinus and aortic nerves on respiratory control of infant rats Am J Physiol 1986, 251 R811-7
19. Walker JK ,Jennmgs DB Ventilatory effects of angiotensin and vasopressin m conscious rats Can J Physiol Pharmacol 1996, 74 1258-64
20. Trbovic SM, Carley DW, Radulovacki M ProtoveratnnesA and B increase sleep apnea index m Sprague-Dawley rats J Appl Physwl 1997, 83 1602-6
21. Salamone JA, Strohl KP, Wemer DM et al. Cranial and phrenic nerve responses to changes m systemic blood pressure JAppl Physiol 1983,55 61-8
22. Wasicko MJ, Gienng RW, Knuth SL, Leiter JC Hypoglossal and phrenic nerve responses to carotid baroreceptor stimulation J Appl Physiol 1993, 75 1395-403
23. van den Auirdweg JG, Karemaker JM Repetitive apneas induce penodic hypertension in normal subjects through hypoxia JAppl Physiol 1992 Mar, 72 (3) 821-7
24. Fletcher EC, Lesske J, Qian W et al. Repetitive, episodic hypoxia causes diurnal elevation of systemic blood pressure m rats Hypertension 1992, 19 555-61
25. Fletcher EC, Bao G, Li R Renm activity and blood pressure in response to chronic episodic hypoxia Hypertension 1999 Aug 34 (2) 309-14
26. Carlson JT, Hedner J, Elam M et al. Augmented resting sympathetic activity m awake patients with obstructive sleep apnea Chest 1993 Jun, 103 (6) 1763-8
27. Dimsdale JE, Coy T, Ziegler MG et al. The effect of sleep apnea on plasma and unnary catecholamines Sleep 1995Jun, 18 (5) 377-81
28. Beau SL, Tolley TK, Saffitz JE Heterogeneous transmural distribution of beta-adrenergic receptor subtypes m failing human hearts Circulation 1993, 88 2501-9
29. Grote L, Kraiczi H, Hedner J Reduced alpha- and beta(2)-adrenergic vascular response m patients with obstructive sleep apnea Am J Respir Cnt Care Med 2000 Oct, 162 (4 Pt I) 1480-7
30. Hedner J, Darpo B, Ejnell H et al. Reduction in sympathetic activity after longterm CPAP treatment m sleep apnoea cardiovascular implications Eur Respir J 1995 Feb, 8 (2) 222-9
31. Warley AR, StradlmgJR Abnormal diurnal variation m salt and water excretion m patients with obstructive sleep apnoea Chn Sci (Lond) 1988 Feb, 74 (2) 183-5
32. Kneger J, Imbs JL, Schmidt M, KurtzD Renalfunction m patients with obstructive sleep apnea Effects of nasal continuous positive airway pressure Arch Intern Med 1988 Jun, 148 (6) 1337-40
33. Ehlenz K, Schmidt P, Podzsus Tetal Plasma levels of atnal natruretic factor m patients with sleep apnea syndrome Acta Endocnnol 1988, 287 Suppl 234-5
34. Kneger J, Laks L, Wilcox I et al. Atnal natriuretic peptide release dunng sleep m patients with obstructive sleep apnoea before and dunng treatment with nasal continuous positive airway pressure Clm Sci (Lond) 1989 Oct, 77 (4) 407-11
35. Ehlenz K, Peter JH, Kaffamik H, von Wiehert P Pneumologie 1991, 45 (suppl I) 239-45
36. Kneger J, Schmidt M, Sforza E et al. Unnary excretion ofguanosine 3' 5'-cyclic monophosphate dunng sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment Clin Sci (Lond) 1989 Jan, 76(1) 31-7
37. Kneger J, Follenius M, Sforza E et al. Effects of treatment with nasal continuous positive airway pressure on atnal natnuretic peptide and arginine vasopressin release dunng sleep in patients with obstructive sleep apnoea Clin Sci (Lond) 1991 May, 80 (5) 443-9
38. Yalkut D, Lee LY, Gnder J et al. Mechanism of atnal natnuretic peptide release with increased inspiratory resistance J Lab Clin Med 1996 Sep, 128 (3) 322-8
39. Mackay TW, Fitzpatnck MF, Freestone S et al. Atnal natnuretic peptide levels m the sleep apnoea/hypopnoea syndrome Thorax 1994 Sep, 49 (9) 920-1
40. Liu S, Liu L Effect of treatment with continuous positive airway pressure on nocturnal polyuna in patients with obstructive sleep apnea syndrome Zhonghua Jie He He Hu Xi Za Zhi 2001 Mar, 24 (3) 158-60
41. Baruzzi A, Riva R, Cingnotta F et al. Atnal natnuretic peptide and catecholamines m obstructive sleep apnea syndrome Sleep 1991 Feb, 14 (I) 83-6
42. Ehlenz K, Firle K, Schneider H et al. Reduction of nocturnal diuresis and natnuresis dunng treatment of obstructive sleep apnea (OSA) with nasal continuous positive air pressure (nCPAP) correlates to cGMP excretion Med Klm 1991 Jun 15,86(6) 294-6,332
43. LinCC, Tsan KW, Lm CY Plasma levels of atnal natnuretic factor m moderate to severe obstructive sleep apnea syndrome Sleep 1993 Jan, 16 (I) 37-9
44. Saarelamen S, Seppala E, Laasonen K, Hasan J Circulating endothelin-1 m obstructive sleep apnea Endothelium 1997,5 (2) 115-8
45. Phillips BG, Narkiewicz K, Pesek CA et al. Effe cts of obstructive sleep apnea on endothelm-1 and blood pressure J Hypertens 1999Jan, 17 (I) 61-6
46. Grimpen F, Kanne P, Schulz E et al. Endothelm-1 plasma levels are not elevated mpatients with obstructive sleep apnoea Eur RespirJ 2000 Feb, 15 (2) 320-5
47. Kanagy NL, Walker BR, Nelm LD Role ofendothelin in intermittent hypoxia-mducedhypertension Hypertension 2001 Feb, 37 (2 Pan2) 511-5
48. Kneger J, Benzom D, Sforza E, Sassard J Unnary excretion of prostanoids during sleep m obstructive sleep apnoea patients Clm Exp Pharmacol Physiol 1991 Aug 18(8) 551-5
49. Kimura H, Nujima M, Abe Y et al. Compensatory excretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome Intern Med 1998 Feb, 37 (2) 127-33
50. Rodenstem DO, D'Odemont JP, Pieters T, Aubert-Tulkens G Diurnal and nocturnal diuresis and natnuresis m obstructive sleep apnea Effects of nasal continuous positive airway pressure therapy Am Rev Respir Dis 1992 Jun, 145 (6) 1367-71
51. Follemus M, Kneger J, Krauth MO et al. Obstructive sleep apnea treatment peripheral and central effects on plasma renm activity and aldosterone Sleep 1991 Jun, 14(3) 211-7
52. Ehlenz K, Peter JH, SchneiderHet al. Renin secretion is substantially influenced by obstructive sleep apnea syndrome In Home JĄ ed Sleep ’90 Bochum Pontenagel Press, 1990, 193-5
53. Brandenberger G, Follenius M, Simon C et al. Nocturnal oscillations in plasma renm activity and REM-NREM sleep cycles m humans a common regulatory mechanism? Sleep 1988 Jun, 11 (3) 242-50
54. Brandenberger G, Chanfi C, MuzetA et al. Remn as a biological marker of the NREM-REM sleep cycle effect of REM sleep suppression J Sleep Res 1994 Mar, 3 (I) 30-5
55. Pelttan LH, Hietanen EK, Salo TT et al. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing Am J Hypertens 1998Mar, 11 (3 Pt I) 272-9
56. Isaksson H, SvanborgE Obstructive sleep apnea syndrome in male hypenenswes, refractory to drug therapy Nocturnal automatic blood pressure measurements—an aid to diagnosis? Clin Exp HypertensA 1991, 13 (6-7) 1195-212
57. Lavie P, Hoffstem V Sleep apnea syndrome a possible contnbutingfactor to resistant hypenension Sleep 2001 Sep 15, 24 (6) 721-5
58. Калинкин АЛ Роль синдрома апноэ во сне в течение гипертонической болезни Дисс канд мед наук M, 1997
59. Fletcher EC, Debehnke RD, Lovoi MS, Gonn AB Undiagnosed sleep apnea т patients with essential hypertension Ann Intern Med 1985, 103 190-5
60. Guillemmault C, Simmons FB, Motta J et al. Obstructive sleep apnea syndrome and tracheostomy Long-term follow-up experience Arch Intern Med 1981, 141 985-8
61. Peiser J, Lavie P, Ovnat Ą Charuzi I Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery Ann Surg 1984, 199 112-5
62. Jennum P, Wildschiodtz G, Christensen NJ, Schwartz T Blood pressure, catecholamines and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment Am J Hypertens 1989, 2 847-52
63. Wilcox T, Yang TS, HednerJA Is sleep apnea a confounder of the relationship between obesity and systemic hypertension? Circulation 1991, 84 (suppl 2) 136
64. Hall JE, Brands MW, Hildebrandt DA, Mizelle HL Obesity-associated hypertension Hypennsulmemia and renal mechanisms Hypertension 1992, 19 (suppl I) 145-55
65. Silverberg DS, OskenbergA Essential hypenension and abnormal upper airway resistance dunng sleep Sleep 1997, 20 794
66. Becker HF Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure m patients with obstructive sleep apnea Circulation 2003 Jan 7, 107 (I) 68-73
67. Quan SF, Howard BV, Iber C et al. The Sleep Hean Health Study Design, rationale, and methods Sleep 1997, 20 1077
68. Nieto FJ, Young TB, Lmd BK et al. Association of sleep-disordered breathing sleep apnea, and hypertension m a large community-based study Sleep Heart Health Study JAMA 2000 Apr 12, 283 (14) 1829-36